|Articles|March 21, 2023
The Future of Orphan Drugs- Insights on the Current Market, Trends & Strategic Partnerships Driving Innovation
Author(s)Catalent
In this report, we will highlight the trends shaping the orphan-drug market, with a particular focus on expedited drug development. Expert insights on navigating development and manufacturing challenges with orphan drugs will be included, with insights on how drug sponsors of all sizes work with contract development and manufacturing organizations (CDMOs) to achieve their goals.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment
2
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
3
BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation
4
FDA Deploys Agentic AI Capabilities for Agency Staff
5
